J&J strong quarter amplified by new details on Kenvue consum

Johnson & Johnson's management updated their thoughts on how to handle the company's 89.6% interest in Kenvue.

Related Keywords

Jim Cramer , Medtech , Interventional Solutions , Johnson , Jim Cramer Charitable , Consumer Health , Wall Street , Kevnue Consumer , Consumer Second Quarter , Tech Medtech , General Surgery , Advanced Surgery , Charitable Trust ,